Market Cap 8.12B
Revenue (ttm) 3.72B
Net Income (ttm) 55.62M
EPS (ttm) N/A
PE Ratio 17.84
Forward PE 17.11
Profit Margin 1.50%
Debt to Equity Ratio 0.44
Volume 1,009,100
Avg Vol 2,015,650
Day's Range N/A - N/A
Shares Out 92.40M
Stochastic %K 17%
Beta 1.44
Analysts Sell
Price Target $101.35

Company Profile

Qorvo, Inc. engages in development and commercialization of technologies and products for wireless, wired, and power markets in the United States, China, rest of Asia, Taiwan, and Europe. It operates through three segments: High Performance Analog (HPA), Connectivity and Sensors Group (CSG), and Advanced Cellular Group (ACG). The HPA segment supplies radio frequency and power management solutions for defense and aerospace, and 5G and 6G infrastructure markets. The CSG segment supplies connectivi...

Industry: Semiconductors
Sector: Technology
Phone: 336 664 1233
Address:
7628 Thorndike Road, Greensboro, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:11 AM
$QRVO is currently trading at $86.2, below its 30-day (MA30) and 50-day (MA50) moving averages of $90.57 and $90.67, respectively, indicating a bearish trend. The RSI at 41.91 suggests that the stock is nearing oversold conditions but is not yet in that territory, signaling potential for a reversal. The recent trading range shows a 60-day high of $106.3 and a low of $83.12, providing a clear support level at $83.12. Market context indicates weakness, as the price is below key moving averages. A suggested entry point could be around $85.50, with a stop loss set at $83 to limit potential losses. For targets, consider a first target at $90, aligning with the MA30, and a second target at $92, which is a psychological resistance level. This plan capitalizes on a potential short-term reversal while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:17 AM
$QRVO is currently trading at $86.52, with an RSI of 42.5 indicating a neutral to slightly bearish momentum. The stock is below its 30-day MA of 90.84 and 50-day MA of 90.86, suggesting a bearish trend in the short term. The recent high of $106.3 and low of $83.12 over the last 60 days indicates a range-bound market, with current price closer to the lower end. Directional bias is bearish due to the price being below both moving averages and the RSI indicating potential weakness. Suggested entry point is at $85.50, slightly below the current price to capture a potential bounce. Set a stop loss at $83.00 to limit downside risk. Targets can be set at $90.00 (near the 30-day MA) and $92.00 (near the 50-day MA) for potential profit-taking. Monitor for any changes in market conditions or RSI movement for adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:53 AM
$QRVO is currently trading at $86.52, with an RSI of 42.5 indicating a neutral to slightly bearish momentum. The stock is below its 30-day MA of 90.84 and 50-day MA of 90.86, suggesting a bearish trend in the short term. The recent high of $106.3 and low of $83.12 over the last 60 days indicates a range-bound market, with current price closer to the lower end. Directional bias is bearish due to the price being below both moving averages and the RSI indicating potential weakness. Suggested entry point is at $85.50, slightly below the current price to capture a potential bounce. Set a stop loss at $83.00 to limit downside risk. Targets can be set at $90.00 (near the 30-day MA) and $92.00 (near the 50-day MA) for potential profit-taking. Monitor for any changes in market conditions or RSI movement for adjustments. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Nov. 11 at 5:21 PM
$QRVO Opportunity Mizuho raises target price to $93 from $75 Mizuho raises to neutral from underperform
0 · Reply
topstockalerts
topstockalerts Nov. 11 at 1:35 PM
Mizuho upgraded Skyworks Solutions and Qorvo to Neutral following their planned merger, saying the deal offers “some valuation synergies” despite mobile market challenges. The merger is expected to close in April 2027 and generate about $500 million in annual cost synergies by CY28–29E, positioning the combined firm as the largest global RF player with over 25% share, surpassing QCOM. For Skyworks, Mizuho raised its target to $73 from $65, citing a pro forma FY27E EPS of $5.83 and fair value near $82 per share, while noting risks such as heavy AAPL exposure, Chinese RF competition, and a projected 7% iPhone sales drop in CY26E. Qorvo’s target rose to $93 from $75, implying ~$103 per share before a 10% discount for China regulatory delays. Mizuho said the merger offers short-term support but warned that full synergies will take time to realize and that mobile and China headwinds persist, though a late-2026 analog rebound could help. $SWKS $QRVO $QCOM $AAPL
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 10:58 AM
Mizuho has adjusted their stance on Qorvo ( $QRVO ), setting the rating to Neutral with a target price of 75 → 93.
0 · Reply
Funxs
Funxs Nov. 8 at 7:07 PM
$QRVO $ZOMDF ahh Kevin Klass just bought 250,000 more shares anyone want to guess where he spent most of his career at - Heska / Mars for 12 yrs before coming to Zomedica in 2023 and he owned shares of ZOM before being hired - he would understand the situation below better than anyone. FYI he worked at Baxter and Siemens before Heska so I think his stock purchases also carry weight.
1 · Reply
Funxs
Funxs Nov. 7 at 6:26 PM
$ZOMDF don’t forget Johnny Powers was highly respected at $IDXX and came here to create the next idexx and found the tech at $QRVO
0 · Reply
Lambition
Lambition Nov. 7 at 5:23 PM
$QRVO $ZOMDF Mars paid $1.3 billion for Heska — and Zomedica now owns the same diagnostic platform lineage (Rapid Diagnostek → Qorvo → ZOMDF) that Heska once tried to secure. If ZOMDF scales both its vet + human businesses and simply reaches one-fifth of Heska’s revenue (~$50 M–$60 M), a $500$700 M market cap (≈ $0.50–$0.70 per share) is a realistic, conservative path — and that’s without counting any takeover premium like Mars paid.💎
0 · Reply
Funxs
Funxs Nov. 7 at 4:48 PM
$ZOMDF Heska now Mars would love to have this technology back, before it was acquired by Qorvo the co was formally known as Rapid Diagnostek. Heska sued to try to stop $QRVO from buying it.
1 · Reply
Latest News on QRVO
Qorvo, Inc. (QRVO) Q2 2026 Earnings Call Transcript

Nov 3, 2025, 7:56 PM EST - 10 days ago

Qorvo, Inc. (QRVO) Q2 2026 Earnings Call Transcript


Qorvo, Inc. (QRVO) M&A Call Transcript

Oct 28, 2025, 11:01 AM EDT - 17 days ago

Qorvo, Inc. (QRVO) M&A Call Transcript


Why is Skyworks paying a hefty premium for Qorvo stock?

Oct 28, 2025, 10:58 AM EDT - 17 days ago

Why is Skyworks paying a hefty premium for Qorvo stock?

SWKS


Earnings Charge Forward, SWKS-QRVO Merger Watch

Oct 28, 2025, 8:55 AM EDT - 17 days ago

Earnings Charge Forward, SWKS-QRVO Merger Watch

SWKS


Qorvo's Better Than A Nice Quarter

Aug 22, 2025, 11:48 AM EDT - 3 months ago

Qorvo's Better Than A Nice Quarter


Qorvo: The Defense Angle No One Sees

Aug 14, 2025, 12:57 PM EDT - 3 months ago

Qorvo: The Defense Angle No One Sees


Qorvo, Inc. (QRVO) Q1 2026 Earnings Call Transcript

Jul 29, 2025, 7:43 PM EDT - 3 months ago

Qorvo, Inc. (QRVO) Q1 2026 Earnings Call Transcript


Qorvo® Announces Fiscal 2026 First Quarter Financial Results

Jul 29, 2025, 4:00 PM EDT - 3 months ago

Qorvo® Announces Fiscal 2026 First Quarter Financial Results


Gauging Qorvo's Financial Stance

May 8, 2025, 8:54 AM EDT - 6 months ago

Gauging Qorvo's Financial Stance


Qorvo, Inc. (QRVO) Q4 2025 Earnings Conference Call Transcript

Apr 29, 2025, 7:08 PM EDT - 7 months ago

Qorvo, Inc. (QRVO) Q4 2025 Earnings Conference Call Transcript


Qorvo® Announces Fiscal 2025 Fourth Quarter Financial Results

Apr 29, 2025, 4:00 PM EDT - 7 months ago

Qorvo® Announces Fiscal 2025 Fourth Quarter Financial Results


Qorvo Q4 Earnings Preview: Looking For Any Signs Of A Turnaround

Apr 24, 2025, 3:18 PM EDT - 7 months ago

Qorvo Q4 Earnings Preview: Looking For Any Signs Of A Turnaround


3 Chip Stocks That Face Tariff Risks, Says Analyst

Apr 21, 2025, 12:32 PM EDT - 7 months ago

3 Chip Stocks That Face Tariff Risks, Says Analyst

MCHP TXN


Chipmaker Qorvo appoints two industry veterans to board

Apr 14, 2025, 8:47 AM EDT - 7 months ago

Chipmaker Qorvo appoints two industry veterans to board


Qorvo® Announces Results of Board Refreshment Process

Apr 14, 2025, 7:30 AM EDT - 7 months ago

Qorvo® Announces Results of Board Refreshment Process


Qorvo's Business Turn Around:  A Long And Winding Road

Feb 13, 2025, 7:30 AM EST - 9 months ago

Qorvo's Business Turn Around:  A Long And Winding Road


QRVO Down & ASML Up: Impacts from DeepSeek & AAPL Growth

Jan 29, 2025, 9:44 AM EST - 10 months ago

QRVO Down & ASML Up: Impacts from DeepSeek & AAPL Growth

AAPL ASML


Qorvo Analysts Slash Their Forecasts After Q3 Results

Jan 29, 2025, 9:34 AM EST - 10 months ago

Qorvo Analysts Slash Their Forecasts After Q3 Results


Qorvo, Inc. (QRVO) Q3 2025 Earnings Call Transcript

Jan 28, 2025, 7:43 PM EST - 10 months ago

Qorvo, Inc. (QRVO) Q3 2025 Earnings Call Transcript


Qorvo® Announces Fiscal 2025 Third Quarter Financial Results

Jan 28, 2025, 4:00 PM EST - 10 months ago

Qorvo® Announces Fiscal 2025 Third Quarter Financial Results


Qorvo Stock Soars as Starboard Value Takes Stake in Chipmaker

Jan 17, 2025, 12:35 PM EST - 10 months ago

Qorvo Stock Soars as Starboard Value Takes Stake in Chipmaker


Starboard builds stake in Qorvo, WSJ reports

Jan 16, 2025, 7:08 PM EST - 10 months ago

Starboard builds stake in Qorvo, WSJ reports


Starboard Builds Big Stake in Chip Maker Qorvo

Jan 16, 2025, 7:00 PM EST - 10 months ago

Starboard Builds Big Stake in Chip Maker Qorvo


PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:11 AM
$QRVO is currently trading at $86.2, below its 30-day (MA30) and 50-day (MA50) moving averages of $90.57 and $90.67, respectively, indicating a bearish trend. The RSI at 41.91 suggests that the stock is nearing oversold conditions but is not yet in that territory, signaling potential for a reversal. The recent trading range shows a 60-day high of $106.3 and a low of $83.12, providing a clear support level at $83.12. Market context indicates weakness, as the price is below key moving averages. A suggested entry point could be around $85.50, with a stop loss set at $83 to limit potential losses. For targets, consider a first target at $90, aligning with the MA30, and a second target at $92, which is a psychological resistance level. This plan capitalizes on a potential short-term reversal while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:17 AM
$QRVO is currently trading at $86.52, with an RSI of 42.5 indicating a neutral to slightly bearish momentum. The stock is below its 30-day MA of 90.84 and 50-day MA of 90.86, suggesting a bearish trend in the short term. The recent high of $106.3 and low of $83.12 over the last 60 days indicates a range-bound market, with current price closer to the lower end. Directional bias is bearish due to the price being below both moving averages and the RSI indicating potential weakness. Suggested entry point is at $85.50, slightly below the current price to capture a potential bounce. Set a stop loss at $83.00 to limit downside risk. Targets can be set at $90.00 (near the 30-day MA) and $92.00 (near the 50-day MA) for potential profit-taking. Monitor for any changes in market conditions or RSI movement for adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:53 AM
$QRVO is currently trading at $86.52, with an RSI of 42.5 indicating a neutral to slightly bearish momentum. The stock is below its 30-day MA of 90.84 and 50-day MA of 90.86, suggesting a bearish trend in the short term. The recent high of $106.3 and low of $83.12 over the last 60 days indicates a range-bound market, with current price closer to the lower end. Directional bias is bearish due to the price being below both moving averages and the RSI indicating potential weakness. Suggested entry point is at $85.50, slightly below the current price to capture a potential bounce. Set a stop loss at $83.00 to limit downside risk. Targets can be set at $90.00 (near the 30-day MA) and $92.00 (near the 50-day MA) for potential profit-taking. Monitor for any changes in market conditions or RSI movement for adjustments. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Nov. 11 at 5:21 PM
$QRVO Opportunity Mizuho raises target price to $93 from $75 Mizuho raises to neutral from underperform
0 · Reply
topstockalerts
topstockalerts Nov. 11 at 1:35 PM
Mizuho upgraded Skyworks Solutions and Qorvo to Neutral following their planned merger, saying the deal offers “some valuation synergies” despite mobile market challenges. The merger is expected to close in April 2027 and generate about $500 million in annual cost synergies by CY28–29E, positioning the combined firm as the largest global RF player with over 25% share, surpassing QCOM. For Skyworks, Mizuho raised its target to $73 from $65, citing a pro forma FY27E EPS of $5.83 and fair value near $82 per share, while noting risks such as heavy AAPL exposure, Chinese RF competition, and a projected 7% iPhone sales drop in CY26E. Qorvo’s target rose to $93 from $75, implying ~$103 per share before a 10% discount for China regulatory delays. Mizuho said the merger offers short-term support but warned that full synergies will take time to realize and that mobile and China headwinds persist, though a late-2026 analog rebound could help. $SWKS $QRVO $QCOM $AAPL
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 10:58 AM
Mizuho has adjusted their stance on Qorvo ( $QRVO ), setting the rating to Neutral with a target price of 75 → 93.
0 · Reply
Funxs
Funxs Nov. 8 at 7:07 PM
$QRVO $ZOMDF ahh Kevin Klass just bought 250,000 more shares anyone want to guess where he spent most of his career at - Heska / Mars for 12 yrs before coming to Zomedica in 2023 and he owned shares of ZOM before being hired - he would understand the situation below better than anyone. FYI he worked at Baxter and Siemens before Heska so I think his stock purchases also carry weight.
1 · Reply
Funxs
Funxs Nov. 7 at 6:26 PM
$ZOMDF don’t forget Johnny Powers was highly respected at $IDXX and came here to create the next idexx and found the tech at $QRVO
0 · Reply
Lambition
Lambition Nov. 7 at 5:23 PM
$QRVO $ZOMDF Mars paid $1.3 billion for Heska — and Zomedica now owns the same diagnostic platform lineage (Rapid Diagnostek → Qorvo → ZOMDF) that Heska once tried to secure. If ZOMDF scales both its vet + human businesses and simply reaches one-fifth of Heska’s revenue (~$50 M–$60 M), a $500$700 M market cap (≈ $0.50–$0.70 per share) is a realistic, conservative path — and that’s without counting any takeover premium like Mars paid.💎
0 · Reply
Funxs
Funxs Nov. 7 at 4:48 PM
$ZOMDF Heska now Mars would love to have this technology back, before it was acquired by Qorvo the co was formally known as Rapid Diagnostek. Heska sued to try to stop $QRVO from buying it.
1 · Reply
Funxs
Funxs Nov. 7 at 4:01 PM
$ZOMDF vet alone this should be at .40-.50 that’s why insiders were buying at .19. What they acquired from $QRVO / $SWKS is the real deal and they still work together. Imho the human co will be a recognizable company 10x the size of zom and will be the first of other human cos to work with zomedica. He’s sitting on material news you can tell from last 4 @ 4 video.
0 · Reply
Lambition
Lambition Nov. 7 at 4:00 PM
$QRVO $ZOMDF Zomedica quietly bought a $200 M+ human-diagnostic platform for $11 M, secured ISO certification, and is led by a 35-year med-tech veteran now executing in his home field. With $54 M cash and no debt, the setup is fundamentally explosive — the kind of asymmetric trade where the downside is pennies, and the upside is multi-dollar.
0 · Reply
Funxs
Funxs Nov. 7 at 3:49 PM
0 · Reply
RunnerSignals
RunnerSignals Nov. 5 at 8:59 PM
Wall Street upgrading spree hits $JHX $NSSC $QRVO $WELL $WM who's got the biggest upside? One showing 24% potential... Read the full breakdown https://stocksrunner.com/news/2025-11-05-stock-upgrades-today-show-analyst-confidence-in-these-companies
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 6:00 AM
$QRVO beats big in Q2 🚀 Earnings and revenue topped estimates, fueled by solid demand across ACG and HPA segments — a clear sign of renewed strength. See what’s driving QRVO’s momentum this quarter 👉 https://www.zacks.com/stock/news/2784805/qorvo-q2-earnings-surpass-estimates-revenues-rise-yy?cid=sm-stocktwits-2-2784805-teaser-19411&ADID=SYND_STOCKTWITS_TWEET_2_2784805_TEASER_19411
0 · Reply
IN0V8
IN0V8 Nov. 4 at 9:39 PM
$QRVO Added at $88
0 · Reply
Estimize
Estimize Nov. 4 at 8:06 PM
$QRVO reported 49.7% Gross Margins for Q2. http://www.estimize.com/intro/qrvo?chart=historical&metric_name=gross_margins&utm_content=QRVO&u
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 6:22 PM
$QRVO beats big in Q2 🚀 Earnings and revenue topped estimates, fueled by solid demand across ACG and HPA segments — a clear sign of renewed strength. See what’s driving QRVO’s momentum this quarter 👉 https://www.zacks.com/stock/news/2784805/qorvo-q2-earnings-surpass-estimates-revenues-rise-yy?cid=sm-stocktwits-2-2784805-teaser-19411&ADID=SYND_STOCKTWITS_TWEET_2_2784805_TEASER_19411
0 · Reply
Estimize
Estimize Nov. 4 at 5:39 PM
$QRVO reported 49.7% Gross Margins for Q2. http://www.estimize.com/intro/qrvo?chart=historical&metric_name=gross_margins&utm_content=QRVO&u
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 5:22 PM
$QRVO beats estimates — here's what drove the strong Q2 results! 🚀 📈 Year-over-year revenue growth in Advanced Cellular Group & High Performance Analog 💪 Solid momentum in aerospace, defense, and data centers 🔧 Restructuring in Connectivity & Sensors Group to boost future prospects Full breakdown here 👉 https://www.zacks.com/stock/news/2784805/qorvo-q2-earnings-surpass-estimates-revenues-rise-yy?cid=sm-stocktwits-2-2784805-body-19377&ADID=SYND_STOCKTWITS_TWEET_2_2784805_BODY_19377
0 · Reply
Estimize
Estimize Nov. 4 at 3:12 PM
$QRVO reported 49.7% Gross Margins for Q2. http://www.estimize.com/intro/qrvo?chart=historical&metric_name=gross_margins&utm_content=QRVO&u
0 · Reply
Estimize
Estimize Nov. 4 at 12:42 PM
$QRVO reported 49.7% Gross Margins for Q2. http://www.estimize.com/intro/qrvo?chart=historical&metric_name=gross_margins&utm_content=QRVO&u
0 · Reply